Advertisement

The Cerebellum

, Volume 17, Issue 1, pp 4–11 | Cite as

Epidemiology of Cerebellar Diseases and Therapeutic Approaches

  • Michael S. Salman
Review

Abstract

Diseases involving the cerebellum occur relatively commonly in children and adults around the globe. Many factors influence their epidemiology including geography, ethnicity, consanguinity, and the methodology used to ascertain patients. In addition, reliable epidemiological data rely heavily on accurate disease classification. Continuous advances in genetic research and neuroimaging modalities have resulted in improved understanding of cerebellar diseases and have led to several revisions in their classification. Recent global epidemiological studies on ataxia reported an estimated overall prevalence rate of 26/100,000 in children, a prevalence rate of dominant hereditary cerebellar ataxia of 2.7/100,000, and a prevalence rate of recessive hereditary cerebellar ataxia of 3.3/100,000. The management of cerebellar diseases is multidisciplinary and multimodal. General supportive and symptomatic therapies should be initiated. Genetic counseling should be offered, where appropriate. Few drugs, specific motor rehabilitation programs, and noninvasive cerebellar stimulation for the treatment of ataxia have been developed and seem to show early promise, but more studies are needed to replicate and fine-tune their benefits further. Some disease-specific treatments are available. For example, acetazolamide or 4-aminopyridine for patients with episodic ataxia type 2 and vitamin E for patients with ataxia caused by vitamin E deficiency.

Keywords

Cerebellum Motor coordination Epidemiology Management Treatment 

Notes

Acknowledgements

The author thanks the patients and their families, who participated in the Manitoba study, the organizers of the conference, the University of Manitoba, the Health Science Centre Foundation and the Manitoba Medical Service Foundation, the Children’s Hospital Research Institute of Manitoba, and the Children Hospital Foundation. The author also thanks Dr. Fran Booth for her helpful comments on the manuscript.

Compliance with Ethical Standards

Disclosure

None.

Conflict of Interest

The author declares that he has no conflict of interest.

References

  1. 1.
    Pandolfo M, Manto M. Cerebellar and afferent ataxias. Continuum (Minneap Minn). 2013;19(5):1312–43.Google Scholar
  2. 2.
    Boltshauser E. Cerebellum-small brain but large confusion: a review of selected cerebellar malformations and disruptions. Am J Med Genet A. 2004;126:376–85.CrossRefGoogle Scholar
  3. 3.
    Salman MS, Lee EJ, Tjahjadi A, Chodirker BN. The epidemiology of intermittent and chronic ataxia in children in ManitobaCanada. Dev Med Child Neurol. 2013;55(4):341–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Musselman KE, Stoyanov CT, Marasigan R, Jenkins ME, Konczak J, Morton SM, et al. Prevalence of ataxia in children: a systematic review. Neurology. 2014;82(1):80–9.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Bernard G, Shevell M. The wobbly child: an approach to inherited ataxias. Semin Pediatr Neurol. 2008;15(4):194–208.CrossRefPubMedGoogle Scholar
  6. 6.
    Sequeiros J, Martins S, Silveira I. Epidemiology and population genetics of degenerative ataxias. Handb Clin Neurol. 2012;103:227–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42(3):174–83.CrossRefPubMedGoogle Scholar
  8. 8.
    Infante J, Combarros O, Volpini V, Corral J, Llorca J, Berciano J. Autosomal dominant cerebellar ataxias in Spain: molecular and clinical correlations, prevalence estimation and survival analysis. Acta Neurol Scand. 2005;111(6):391–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Tsuji S, Onodera O, Goto J, Nishizawa M. Study Group on Ataxic Diseases. Sporadic ataxias in Japan-a population-based epidemiological study. Cerebellum. 2008;7(2):189–97.CrossRefPubMedGoogle Scholar
  10. 10.
    Anheim M, Fleury M, Monga B, Laugel V, Chaigne D, Rodier G, et al. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics. 2010;11(1):1–12.CrossRefPubMedGoogle Scholar
  11. 11.
    Silva MC, Coutinho P, Pinheiro CD, Neves JM, Serrano P. Hereditary ataxias and spastic paraplegias: methodological aspects of a prevalence study in Portugal. J Clin Epidemiol. 1997;50:1377–84.CrossRefPubMedGoogle Scholar
  12. 12.
    Wedding IM, Kroken M, Henriksen SP, Selmer KK, Fiskerstrand T, Knappskog PM, et al. Friedreich ataxia in Norway - an epidemiological, molecular and clinical study. Orphanet J Rare Dis. 2015;10:108.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Himmelmann K, Hagberg G, Uvebrant P. The changing panorama of cerebral palsy in Sweden. X. Prevalence and origin in the birth-year period 1999-2002. Acta Pediatrica. 2010;99:1337–43.CrossRefGoogle Scholar
  14. 14.
    Esscher E, Flodmark O, Hagberg G, Hagberg B. Non-progressive ataxia: origins, brain pathology and impairments in 78 Swedish children. Dev Med Child Neurol. 1996;38:285–96.CrossRefPubMedGoogle Scholar
  15. 15.
    Oiglane-Shlik E, Talvik T, Zordania R, Põder H, Kahre T, Raukas E, et al. Prevalence of Angelman syndrome and Prader-Willi syndrome in Estonian children: sister syndromes not equally represented. Am J Med Genet A. 2006;140:1936–43.CrossRefPubMedGoogle Scholar
  16. 16.
    Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM. Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain. 2009;132:1577–88.CrossRefPubMedGoogle Scholar
  17. 17.
    Salman MS, Masood S, Azad M, Chodirker BN. Ethnicity and geographic distribution of pediatric chronic ataxia in Manitoba. Can J Neurol Sci. 2014;41:29–36.CrossRefPubMedGoogle Scholar
  18. 18.
    Salman MS, Klassen SF, Johnston JL. Recurrent ataxia in children and adolescents. Can J Neurol Sci. 2017;44(4):375–383.CrossRefPubMedGoogle Scholar
  19. 19.
    Fekete R. Ataxia. In: Jankovic J, editor, Greenamyre JT, editor-in-chief. MedLink Neurology. San Diego: MedLink Corporation. Available at https://www.medlink.com. Last updated: 28th October 2015.
  20. 20.
    Ilg W, Bastian AJ, Boesch S, Burciu RG, Celnik P, Claaßen J, et al. Consensus paper: management of degenerative cerebellar disorders. Cerebellum. 2014;13(2):248–68.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Kearney M, Orrell RW, Fahey M, Brassington R, Pandolfo M. Pharmacological treatments for Friedreich ataxia. Cochrane Database Syst Rev. 2016;8:CD007791.Google Scholar
  22. 22.
    Ristori G, Romano S, Visconti A, Cannoni S, Spadaro M, Frontali M, et al. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology. 2010;74(10):839–45.CrossRefPubMedGoogle Scholar
  23. 23.
    Romano S, Coarelli G, Marcotulli C, Leonardi L, Piccolo F, Spadaro M, et al. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14(10):985–91.CrossRefPubMedGoogle Scholar
  24. 24.
    Vogel AP, Folker J, Poole ML. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes. Cochrane Database Syst Rev. 2014;10:CD008953.Google Scholar
  25. 25.
    Ilg W, Synofzik M, Brötz D, Burkard S, Giese MA, Schöls L. Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology. 2009;73(22):1823–30.CrossRefPubMedGoogle Scholar
  26. 26.
    Ilg W, Brötz D, Burkard S, Giese MA, Schöls L, Synofzik M. Long-term effects of coordinative training in degenerative cerebellar disease. Mov Disord. 2010;25(13):2239–46.CrossRefPubMedGoogle Scholar
  27. 27.
    Miyai I, Ito M, Hattori N, Mihara M, Hatakenaka M, Yagura H, et al. Cerebellar Ataxia Rehabilitation Trialists Collaboration. Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases. Neurorehabil Neural Repair. 2012;26(5):515–22.CrossRefPubMedGoogle Scholar
  28. 28.
    Keller JL, Bastian AJ. A home balance exercise program improves walking in people with cerebellar ataxia. Neurorehabil Neural Repair. 2014;28(8):770–8.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Ilg W, Schatton C, Schicks J, Giese MA, Schöls L, Synofzik M. Video game-based coordinative training improves ataxia in children with degenerative ataxia. Neurology. 2012;79(20):2056–60.CrossRefPubMedGoogle Scholar
  30. 30.
    Shiga Y, Tsuda T, Itoyama Y, Shimizu H, Miyazawa KI, Jin K, et al. Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry. 2002;72(1):124–6.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Grimaldi G, Oulad Ben Taib N, Manto M, Bodranghien F. Marked reduction of cerebellar deficits in upper limbs following transcranial cerebello-cerebral DC stimulation: tremor reduction and re-programming of the timing of antagonist commands. Front Syst Neurosci. 2014;8:9.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Grimaldi G, Argyropoulos GP, Boehringer A, Celnik P, Edwards MJ, Ferrucci R, et al. Non-invasive cerebellar stimulation—a consensus paper. Cerebellum. 2014;13(1):121–38.CrossRefPubMedGoogle Scholar
  33. 33.
    Benussi A, Dell'Era V, Cotelli MS, Turla M, Casali C, Padovani A, et al. Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. Brain Stimul. 2017;10(2):242–50.CrossRefPubMedGoogle Scholar
  34. 34.
    Parker CC, Evans OB. Metabolic disorders causing childhood ataxia. Semin Pediatr Neurol. 2003;10(3):193–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Vedanarayanan VV. Mitochondrial disorders and ataxia. Semin Pediatr Neurol. 2003;10(3):200–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Artuch R, Brea-Calvo G, Briones P, Aracil A, Galván M, Espinós C, et al. Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation. J Neurol Sci. 2006;246(1–2):153–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10:13.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Verrotti A, D'Egidio C, Agostinelli S, Gobbi G. Glut1 deficiency: when to suspect and how to diagnose? Eur J Paediatr Neurol. 2012;16(1):3–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Feil K, Bremova T, Muth C, Schniepp R, Teufel J, Strupp M. Update on the pharmacotherapy of cerebellar ataxia and nystagmus. Cerebellum. 2016;15(1):38–42.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Section of Pediatric NeurologyChildren’s HospitalWinnipegCanada
  2. 2.Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health SciencesUniversity of ManitobaWinnipegCanada

Personalised recommendations